Search

Your search keyword '"MacLennan S"' showing total 558 results

Search Constraints

Start Over You searched for: Author "MacLennan S" Remove constraint Author: "MacLennan S"
558 results on '"MacLennan S"'

Search Results

1. Tax Crimes and Illicit Money Flows in the EUs

2. How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis

3. The arc of the Snowball: U-Pb dates constrain the Islay anomaly and the initiation of the Sturtian glaciation

5. PUrE RCT 1: Clinical and cost-effectiveness of flexible ureterorenoscopy and extracorporeal shockwave lithotripsy for lower pole stones ≤10 mm

6. Development of prostate cancer typical case presentations and their usage in OPTIMA’s guideline based decision support tool

7. AGREE II quality assessment of national and international clinical practice guidelines on prostate cancer

8. OPTIMA prostate cancer care pathways - bridging clinical practice guidelines, real world evidence and artificial intelligence to enhance decision-making

9. PUrE RCT 2: Clinical and cost-effectiveness of FURS and percutaneous nephrolithotomy for lower pole stones 10-25mm

10. EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees

11. How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis

12. Erfahrungen mit einem national zentralisierten Herstellungsverfahren für Eigenserum-Augentropfen in England

13. Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial

14. PP 1.15 – 00095 Proviruses persisting during the initial years of suppressive ART are relatively stable in terms of genetic diversity, clonal composition, and inferred integration date distribution

15. Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium

16. Diagnostic and prognostic factors in patients with prostate cancer: a systematic review

17. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer

20. Global variation in quality of transurethral resection of bladder surgery, results from the RESECT study

21. Mapping EAU guideline practice variations across Europe: An audit of ADT before surgery in locally advanced and high-risk prostate cancer in 6315 cases across 31 European countries

24. Introducing PIONEER: a project to harness big data in prostate cancer research

25. Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research (Nature Reviews Urology, (2020), 17, 6, (351-362), 10.1038/s41585-020-0324-x)

28. Learning Together: forging belonging among students with experience of the criminal justice system

34. Secondary treatment for men with localized prostate cancer: A pooled analysis of PRIAS and ERSPC-Rotterdam datasets within the PIONEER data platform

36. Diagnostic and prognostic factors in patients with prostate cancer

37. Evaluating Patient-Reported Outcomes Measures (PROMs) for localised prostate cancer: A systematic review using the Consensus-based Standard for the selection of health Measurement Instruments (COSMIN) methodology

40. Re: Risks and Benefits of Adjuvant Radiotherapy after Inguinal Lymphadenectomy in Node-Positive Penile Cancer: A Systematic Review by the European Association of Urology Penile Cancer Guidelines Panel

42. Author Correction: Introducing PIONEER: A project to harness big data in prostate cancer research (Nature Reviews Urology, (2020), 17, 6, (351-362), 10.1038/s41585-020-0324-x)

43. Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250](S0302283819307638)(10.1016/j.eururo.2019.09.035)

45. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees

46. Reply by Authors

47. PIONEER’s operational definitions: Harmonising clinical characteristics and phenotypes data of prostate cancer patients

48. Identifying the most appropriate instrument for Patient-Reported Outcome Measures (PROMs) in patients with clinically localised prostate cancer

49. PIONEER consensus on clinician reported outcome measurements

50. Initial steps of an online search tool development for diagnostic and prognostic factors in prostate cancer

Catalog

Books, media, physical & digital resources